
Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
CVS announced that it will take part in National Patient Safety Awareness Week, which takes place this year from March 5-11. The company will broadcast prescription safety tips for customers through its in-store radio network during the week of the campaign.
CVS recognizes National Patient Safety Awareness Week
CVS announced that it will take part in National Patient Safety Awareness Week, which takes place this year from March 5-11. The company will broadcast prescription safety tips for customers through its in-store radio network during the week of the campaign.
To see more Hot off the Press news articles, click here






